AGP Picks
View all

Healthcare Times Utah
Provided by AGP

Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 12, 2026

Senior Housing Boom Creates Massive Opportunity for Investors, Says Jerry Vinci on The Wealth Flow
Aug. 12, 2026

Senior Housing Boom Creates Massive Opportunity for Investors, Says Jerry Vinci on The Wealth Flow

Indeterminate EIN Presswire
Senior Housing Supply Shortage Threatens Industry, Says Jerry Vinci on On The Market
Aug. 12, 2026

Senior Housing Supply Shortage Threatens Industry, Says Jerry Vinci on On The Market

Indeterminate EIN Presswire
Diathrive Health and MitaRev Partner to Bring Metabolic Support to the Cancer Journey
Aug. 12, 2026

Diathrive Health and MitaRev Partner to Bring Metabolic Support to the Cancer Journey

Indeterminate EIN Presswire
NOTICE TO DISREGARD -- Leading Edge Health Inc
Aug. 12, 2026

NOTICE TO DISREGARD -- Leading Edge Health Inc

Indeterminate GlobeNewswire
WB Blends and Yellow Emperor Announce Strategic Partnership
Aug. 12, 2026

WB Blends and Yellow Emperor Announce Strategic Partnership

Indeterminate EIN Presswire
DM Injury Law Reaches $2.5 Million Settlement for Delivery Driver Injured in Illinois Crash
Aug. 12, 2026

DM Injury Law Reaches $2.5 Million Settlement for Delivery Driver Injured in Illinois Crash

Indeterminate GlobeNewswire
NurExone Announces Binding MOU with Made Scientific for U.S. GMP Manufacturing and Commercial Supply Partnership
Aug. 12, 2026

NurExone Announces Binding MOU with Made Scientific for U.S. GMP Manufacturing and Commercial Supply Partnership

Indeterminate GlobeNewswire
Park Dental Partners Announces Second Quarter 2026 Results
Aug. 12, 2026

Park Dental Partners Announces Second Quarter 2026 Results

Indeterminate GlobeNewswire
Reviva Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug. 12, 2026

Reviva Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 12, 2026

AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
Aug. 12, 2026

First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Aug. 12, 2026

BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Indeterminate GlobeNewswire
Range Impact Reports 2Q 2026 Financial Results
Aug. 12, 2026

Range Impact Reports 2Q 2026 Financial Results

Indeterminate GlobeNewswire
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
Aug. 12, 2026

Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide

Indeterminate GlobeNewswire
Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update
Aug. 12, 2026

Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire
Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug. 12, 2026

Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug. 12, 2026

Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates
Aug. 12, 2026

Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update
Aug. 12, 2026

Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
Aug. 12, 2026

Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Times Utah

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.